医学
肿瘤科
生物标志物
内科学
循环肿瘤DNA
膀胱癌
尿路上皮癌
前瞻性队列研究
佐剂
辅助治疗
癌症
生物化学
化学
作者
Camilla M. Grunewald,Guenter Niegisch,Peter Albers
标识
DOI:10.1016/j.euf.2022.04.001
摘要
Recent data from IMvigor010 impressively demonstrate the potential of circulating tumor DNA (ctDNA) as a prognostic and a predictive biomarker in patients with urothelial carcinoma. Although ctDNA status was prospectively assessed, the published data are only exploratory and require further prospective validation. Results from the IMvigor011 trial are therefore eagerly awaited.
科研通智能强力驱动
Strongly Powered by AbleSci AI